Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Horizonte sanitario
versión On-line ISSN 2007-7459versión impresa ISSN 1665-3262
Resumen
VAZQUEZ-MEDINA, Martín Uriel et al. Association of ABO blood type with mortality in hospitalized patients with COVID-19. Horiz. sanitario [online]. 2022, vol.21, n.1, pp.17-24. Epub 26-Mayo-2023. ISSN 2007-7459. https://doi.org/10.19136/hs.a21n1.4516.
Objective:
To explore the relation between ABO blood group system and in-hospital mortality in Mexican patients admitted with COVID-19.
Materials and methods:
We performed a retrospective study with 2,369 hospitalized patients with confirmed SARS-CoV-2 infection in a tertiary referral hospital, admitted between March 27 and December 10, 2020. Data were obtained from electronic health records. Adjusted and unadjusted Cox Proportional-Hazard models were performed to test the association of ABO blood groups with mortality of COVID-19 patients. The variables considered for adjustment of the models were age, sex, and main comorbidities.
Results:
Out of all studied patients, group O was the most frequent blood type with 1999 patients (84.3%), followed by group A (11.3%), B (3.5%) and AB (0.72%). Blood group A was associated with a lower hazard of death among COVID-19 patients compared with group O (adjusted HR = 0.72, 95% IC 0.55-0.95, P = 0.02. Groups B, AB and Positive Rh were not significantly associated with the outcome.
Conclusions:
We found evidence of a statistically significant association between ABO blood type and COVID-19 in-hospital death. Patients with blood group A may be less likely to die during hospitalization compared with group O.
Palabras llave : COVID-19; Blood Group Antigens; Mortality; Prognosis..